Showing results (1571-1580 of 1,870) with videos related to

Sort By:
Pageof 187
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
Unique amalgamation of primary and secondary structural elements transform peptaibols into potent bioactive cell-penetrating peptidesLin Du, April L Risinger, Carter A Mitchell, et al.
Ebiomedicine|December 31, 2018
Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family StudyPaul N Jensen, Amanda M Fretts, Chaoyu Yu, et al.
Hypertension (Dallas, Tex. : 1979)|September 4, 2024
Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021Joshua A Jacobs, Anthony Rodgers, Brandon K Bellows, et al.
Circulation. Heart Failure|November 14, 2019
Characteristics and Healthcare Utilization Among Veterans Treated for Heart Failure With Reduced Ejection Fraction Who Switched to Sacubitril/ValsartanApril F Mohanty, Emily B Levitan, John A Dodson, et al.
The Journal of Nutrition|December 25, 2015
Associations of Plasma Phospholipid SFAs with Total and Cause-Specific Mortality in Older Adults Differ According to SFA Chain LengthAmanda M Fretts, Dariush Mozaffarian, David S Siscovick, et al.
The American Journal of Clinical Nutrition|March 20, 2015
Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health StudyRozenn N Lemaitre, Amanda M Fretts, Colleen M Sitlani, et al.
Current Biology : CB|August 12, 2025
Primary auditory cortex is necessary for the acquisition and expression of categorical behaviorRebecca F Krall, Rachel M Cassidy, Madan Ghimire, et al.
The New England Journal of Medicine|September 8, 2006
Enoxaparin versus unfractionated heparin in elective percutaneous coronary interventionGilles Montalescot, Harvey D White, Richard Gallo, et al.
JACC. Cardiovascular Interventions|November 21, 2009
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trialGilles Montalescot, Richard Gallo, Harvey D White, et al.
Diabetes|March 29, 2018
Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family StudyRozenn N Lemaitre, Chaoyu Yu, Andrew Hoofnagle, et al.
Pageof 187